Stefan Coassin

ORCID: 0000-0001-5677-8979
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Genetic Associations and Epidemiology
  • Cancer, Lipids, and Metabolism
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cholesterol and Lipid Metabolism
  • Atherosclerosis and Cardiovascular Diseases
  • Liver Disease Diagnosis and Treatment
  • RNA and protein synthesis mechanisms
  • Lipid metabolism and disorders
  • Adipokines, Inflammation, and Metabolic Diseases
  • Genomics and Rare Diseases
  • Peroxisome Proliferator-Activated Receptors
  • Molecular Biology Techniques and Applications
  • Genetic Mapping and Diversity in Plants and Animals
  • RNA Research and Splicing
  • RNA modifications and cancer
  • Chronic Kidney Disease and Diabetes
  • Renal Diseases and Glomerulopathies
  • Advanced Proteomics Techniques and Applications
  • Lipid metabolism and biosynthesis
  • Systemic Lupus Erythematosus Research
  • Marine Ecology and Invasive Species
  • Gout, Hyperuricemia, Uric Acid
  • Metabolomics and Mass Spectrometry Studies
  • Diet, Metabolism, and Disease

Innsbruck Medical University
2016-2025

Universität Innsbruck
2015-2024

University of Lübeck
2016

Institut für Medizinische Informatik, Biometrie und Epidemiologie
2016

University Medical Center
2016

Jena University Hospital
2016

University of Freiburg
2016

University of Regensburg
2008

Helmholtz Zentrum München
2008

Ludwig-Maximilians-Universität München
2008

Amand F. Schmidt Daniel I. Swerdlow Michael V. Holmes Riyaz Patel Zammy Fairhurst-Hunter and 95 more Donald M. Lyall Fernando Pires Hartwig Bernardo Lessa Horta Elina Hyppönen Christine Power Max Moldovan Erik Van Iperen G. Kees Hovingh Ilja Demuth Kristina Norman Elisabeth Steinhagen‐Thiessen Juri Demuth Lars Bertram Tian Liu Stefan Coassin Johann Willeit Stefan Kiechl Karin Willeit Dan Mason John Wright Richard Morris Goya Wanamethee Peter H. Whincup Yoav Ben‐Shlomo Stela McLachlan Jackie F. Price Mika Kivimäki Catherine Welch Adelaida Sánchez-Gálvez Pedro Marques‐Vidal Andrew Nicolaides Andrie G. Panayiotou N. Charlotte Onland‐Moret Yvonne T. van der Schouw Giuseppe Matullo Giovanni Fiorito Simonetta Guarrera Carlotta Sacerdote Nicholas J. Wareham Claudia Langenberg Robert A. Scott Jian’an Luan Martin Bobák Sofia Malyutina Andrzej Pająk Růžena Kubínová Abdonas Tamošiūnas Hynek Pikhart Lise Lotte N. Husemoen Niels Grarup Oluf Pedersen Torben Hansen Allan Linneberg Kenneth Starup Simonsen Jackie A. Cooper Steve E. Humphries Murray H. Brilliant Terrie Kitchner Hákon Hákonarson David Carrell Catherine A. McCarty H. Lester Kirchner Eric B. Larson David R. Crosslin Mariza de Andrade Dan M. Roden Joshua C. Denny Cara L. Carty Stephen Hancock John Attia Elizabeth G. Holliday Martin O’Donnell Salim Yusuf Michael Chong Guillaume Paré Pim van der Harst M. Abdullah Said Ruben N. Eppinga Niek Verweij Harold Snieder Tim Christen Dennis O. Mook‐Kanamori Stefan Gustafsson Lars Lind Erik Ingelsson Raha Pazoki Oscar H. Franco Albert Hofman André G. Uitterlinden Abbas Dehghan Alexander Teumer Sebastian E. Baumeister Marcus Dörr Markus M. Lerch Uwe Völker

Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with reductions both concentration of LDL cholesterol risk coronary heart disease, but also modest hyperglycaemia, increased bodyweight, modestly type 2 diabetes, which no way offsets their substantial benefits. We sought to investigate associations cholesterol-lowering PCSK9 diabetes related biomarkers gauge likely effects inhibitors on risk.In this mendelian randomisation study, we used data from cohort...

10.1016/s2213-8587(16)30396-5 article EN cc-by The Lancet Diabetes & Endocrinology 2016-11-28

Family studies suggest a genetic component to the etiology of chronic kidney disease (CKD) and end stage renal (ESRD). Previously, we identified 16 loci for eGFR in genome-wide association studies, but associations these single nucleotide polymorphisms (SNPs) incident CKD or ESRD are unknown. We thus investigated with 26,308 individuals European ancestry free at baseline drawn from eight population-based cohorts followed median 7.2 years (including 2,122 cases defined as <60ml/min/1.73m2...

10.1371/journal.pgen.1002292 article EN cc-by PLoS Genetics 2011-09-29
Alexander Teumer Adrienne Tin Rossella Sorice Mathias Gorski Nan Cher Yeo and 95 more Audrey Y. Chu Man Li Yong Li Vladan Mijatovic Yi-An Ko Daniel Taliun Alessandro Luciani Ming‐Huei Chen Qiong Yang Meredith C. Foster Matthias Olden Linda T. Hiraki Bamidele O. Tayo Christian Fuchsberger Aida Karina Dieffenbach Alan R. Shuldiner Albert V. Smith Allison Zappa Antonio Lupo Barbara Kollerits Belén Ponte Bénédicte Stengel Bernhard K. Krämer Bernhard Paulweber Braxton D. Mitchell Caroline Hayward Catherine Helmer Christa Meisinger Christian Gieger Christian M. Shaffer Christian Müller Claudia Langenberg Daniel Ackermann David S. Siscovick Eric Boerwinkle Florian Kronenberg Georg Ehret Georg Homuth Gérard Waeber Gerjan Navis Giovanni Gambaro Giovanni Malerba Guðný Eiríksdóttir Li Guo H.-Erich Wichmann Harald Grallert Henri Wallaschofski Henry Völzke Hermann Brenner Holly Kramer Irene Mateo Leach Igor Rudan Hans L. Hillege J. Beckmann Jean‐Charles Lambert Jian’an Luan Jing Zhao John Chalmers Josef Coresh Joshua C. Denny Katja Butterbach Lenore J. Launer Luigi Ferrucci Lyudmyla Kedenko Margot Haun Marie Metzger Mark Woodward Matthew Hoffman Matthias Nauck Mélanie Waldenberger Menno Pruijm Murielle Bochud Myriam Rheinberger Niek Verweij Nicholas J. Wareham Nicole Endlich Nicole Soranzo Ozren Polašek Pim van der Harst Peter P. Pramstaller Péter Vollenweider Philipp S. Wild Ron T. Gansevoort Rainer Rettig Reiner Biffar Robert J. Carroll Ronit Katz Ruth J. F. Loos Shih‐Jen Hwang Stefan Coassin Sven Bergmann Sylvia E. Rosas Sylvia Stracke Tamara B. Harris Tanguy Corre

Elevated concentrations of albumin in the urine, albuminuria, are a hallmark diabetic kidney disease and associated with an increased risk for end-stage renal cardiovascular events. To gain insight into pathophysiological mechanisms underlying we conducted meta-analyses genome-wide association studies independent replication up to 5,825 individuals European ancestry diabetes 46,061 without diabetes, followed by functional studies. Known associations variants CUBN, encoding cubilin, urinary...

10.2337/db15-1313 article EN Diabetes 2015-12-02

Significance Although sequencing of the human genome was completed years ago, we still do not know about physiological significance thousands predicted proteins, particularly membrane proteins. On other hand, for approximately 100 enzymes, no coding gene is known even though their enzymatic reaction has been well characterized. In this work, assign one those proteins (transmembrane protein 189; TMEM189) to reactions with an uncharacterized (plasmanylethanolamine desaturase). This enzyme...

10.1073/pnas.1917461117 article EN cc-by Proceedings of the National Academy of Sciences 2020-03-24

Abstract Background Medical results generated by European CE Marking for In Vitro Diagnostic or in-house tests should be traceable to higher order reference measurement systems (RMS), such as International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)-endorsed procedures (RMPs) materials. Currently, serum apolipoprotein (a) [apo(a)] is recognized a novel risk factor cardiovascular assessment patient management. The former RMS apo(a) no longer available; consequently, an...

10.1093/clinchem/hvac204 article EN cc-by-nc-nd Clinical Chemistry 2023-01-16

Lp(a) concentrations represent a major cardiovascular risk factor and are almost entirely controlled by one single locus (LPA). However, many genetic factors in LPA governing the enormous variance of levels still unknown. Since up to 70% coding sequence located difficult access hypervariable copy number variation named KIV-2, we hypothesized that it may contain novel functional variants with pronounced effects on concentrations. We performed large scale mutation analysis KIV-2 using an...

10.1093/eurheartj/ehx174 article EN cc-by-nc European Heart Journal 2017-03-22

Alterations of mitochondrial DNA (mtDNA) copy number have been associated with a wide variety phenotypes and diseases. Unfortunately, the literature provides scarce methodical information about duplex targeting nuclear mtDNA that meets quality criteria for qPCR. Therefore, we established method quantification using quantitative PCR assay allows simultaneous single gene (beta-2-microglobulin) t-RNALeu on mtDNA. We include plasmid containing both targets in order to normalize against...

10.1038/s41598-018-33684-5 article EN cc-by Scientific Reports 2018-10-12

Current dyslipidemia management in patients with atherosclerotic cardiovascular disease (ASCVD) is based on traditional serum lipids. Yet, there some indication from basic research that apolipoproteins A-I, (a), B, C-I, C-II, C-III, and E may give better pathophysiological insight into the root causes of dyslipidemia. To facilitate future adoption clinical apolipoprotein (apo) profiling for precision medicine, strategies accurate testing should be developed advance. Recent discoveries...

10.1093/clinchem/hvaa239 article EN cc-by-nc Clinical Chemistry 2020-09-24

Lipoprotein(a) (Lp(a)) concentrations are a major independent risk factor for coronary artery disease (CAD) and mainly determined by variation in LPA. Up to 70% of the LPA coding sequence is located hypervariable kringle IV type 2 (KIV-2) region. It hardly accessible conventional technologies, but may contain functional variants. This study sought investigate new, very frequent splicing variant KIV-2 4733G>A on Lp(a) CAD. We genotyped GCKD (German Chronic Kidney Disease) (n = 4,673)...

10.1016/j.jacc.2021.05.037 article EN cc-by Journal of the American College of Cardiology 2021-07-26

Abstract Background Elevated concentrations of lipoprotein(a) [Lp(a)] are directly related to an increased risk cardiovascular diseases, making it a relevant biomarker for clinical assessment. However, the lack global standardization current Lp(a) measurement procedures (MPs) leads inconsistent patient care. The International Federation Clinical Chemistry and Laboratory Medicine working group on quantitating apolipoproteins by mass spectrometry (MS) aims develop next-generation SI...

10.1093/clinchem/hvac203 article EN cc-by Clinical Chemistry 2023-01-16

Abstract Polygenic scores (PGS) enable the prediction of genetic predisposition for a wide range traits and diseases by calculating weighted sum allele dosages variants associated with trait or disease in question. Present approaches PGS from genotypes are often inefficient labor-intensive, limiting transferability into clinical applications. Here, we present ‘Imputation Server PGS’, an extension Michigan Imputation designed to automate standardized calculation polygenic based on imputed...

10.1093/nar/gkae331 article EN cc-by Nucleic Acids Research 2024-05-06

Background— High-density lipoprotein cholesterol (HDLC) is a strong risk factor for atherosclerosis and assumed to be under considerable genetic control. We aimed identify gene regions that influence HDLC levels by genome-wide association analysis in the population-based KORA (Cooperative Health Research Region of Augsburg) study. Methods Results— In S3/F3 (n=1643), we analyzed 377 865 quality-checked single-nucleotide polymorphisms (SNPs; 500K, Affymetrix, Santa Clara, Calif), complemented...

10.1161/circgenetics.108.776708 article EN Circulation Cardiovascular Genetics 2008-10-01

High serum uric acid levels lead to gout and have been reported be associated with an increased risk of hypertension, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease. Recently, the putative fructose transporter SLC2A9 was influence levels. The aim present study examine association four single nucleotide polymorphisms within this gene determine whether is modified by obesity.

10.2337/dc08-0349 article EN cc-by-nc-nd Diabetes Care 2008-06-07
Coming Soon ...